Ntbc (DrugBank: -)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 241 | 高チロシン血症1型 | 2 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00004443 (ClinicalTrials.gov) | October 1998 | 18/10/1999 | Study of NTBC for Tyrosinemia I | Tyrosinemia I | Drug: NTBC | University of Washington | NULL | Completed | N/A | 17 Years | Both | 20 | N/A | United States;Canada | |
| 2 | NCT00004333 (ClinicalTrials.gov) | November 1994 | 18/10/1999 | Phase II Study of the Enzyme Inhibitor NTBC for Tyrosinemia Type I | Tyrosinemia, Type I | Drug: NTBC | National Center for Research Resources (NCRR) | University of Michigan | Completed | N/A | N/A | Both | Phase 2 | NULL |